Dr. Julia Pomoransky is a business development and product development professional with over a decade of experience in the life sciences biotechnology industry. She is a passionate entrepreneur and has participated in the start-up, financing, and operations of several organizations. Most recently, Dr. Pomoransky founded Prosilience Biotech Inc. – a life science organization that supports biotechnology companies with their business development initiatives. Her experience and contributions with start-up organizations has focused on business development but transcends additional functional areas including product development, program/alliance management, and GMP/CMC technical operations. Dr. Pomoransky was one of the first employees of Turnstone Biologics, (NASDAQ: TSBX), an immuno-oncology company with headquarters in San Diego. While at Turnstone Biologics, Dr. Pomoransky’s contributions to Business Development initiatives were critical for the growth of the company spanning acquisitions, licensing, and clinical/research collaborations. In her former role with the BMC Dr. Pomoransky was successful at building a profitable organization, where she was responsible for business operations, technical operations, and business development. Dr. Pomoransky received a Ph.D. in Biochemistry from the University of Ottawa working with Dr. John Bell, and a B.Sc. in Biotechnology from Brock University.
